US Patent 10442815 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
Patent 10442815 was granted and assigned to Karus Therapeutics on October, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 19, 2016
0
Date of Patent
October 15, 2019
0
Patent Applicant
Patent Application Number
15753358
0
Patent Citations Received
Patent Inventor Names
Franck A. Silva
0
Stephen J. Shuttleworth
0
Alexander R. L. Cecil
0
Alice E. Gatland
0
Daniel J. Finnemore
0
Rikki P. Alexander
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10442815 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
